Industry Developments

BMI View: With Latin America's economic outlook looking increasingly positive and consumer demand for pharmaceutical goods becoming more discerning, we believe key markets across the... 2011-10-12

BMI View: Despite Moksha8's impressive track record in commercialising third-party branded medicines in Brazil and Mexico, we believe the company's future success could be severely... 2011-10-11

BMI View: Despite President Ollanta Humala's government demonstrating a strong will to combat Peru's mounting healthcare problems, we maintain the view that the government's inability... 2011-10-10

BMI View: Switzerland-based Actavis has deflected disappointing news in Poland by announcing an aggressive growth strategy in Latin America. Despite being a late entrant into the region's... 2011-10-07

BMI View: Virtually unknown to foreign investors 20 years ago, Colombia's willingness to adopt international patent standards and liberal trade relations have made multinational drugmakers... 2011-10-06

BMI View: Brazil's state regulator's decision to approve the sale and marketing of a widely banned weight loss supplement, even under strict conditions, raises concerns over patient... 2011-10-05

BMI View: After more than a year of back-door meetings, the ongoing general trade talks between Canada and the European Union could deteriorate if Ottawa resists calls from multinational... 2011-10-04

BMI View: Despite copper exports driving Chile's solid economic growth, the country's continuing struggle with social inequality has left many citizens struggling to meet their healthcare... 2011-10-03

BMI View: Despite Astellas's impressive focus on innovation and its rich cabinet of transplant and urology therapies in early development, the company's decision to stop darexaban mid-way... 2011-09-30

BMI View: BMI View: While pharmaceutical trade between India, Latin America and the Caribbean is forecast to increase, BMI believes Indian distributors will face hurdles in markets... 2011-09-29